333 related articles for article (PubMed ID: 31002639)
1. Surviving Cancer without a Broken Heart.
Caspi O; Aronson D
Rambam Maimonides Med J; 2019 Apr; 10(2):. PubMed ID: 31002639
[TBL] [Abstract][Full Text] [Related]
2. Arterial thrombosis and cancer.
Aronson D; Brenner B
Thromb Res; 2018 Apr; 164 Suppl 1():S23-S28. PubMed ID: 29703480
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity of cancer therapeutics: current issues in screening, prevention, and therapy.
Sheppard RJ; Berger J; Sebag IA
Front Pharmacol; 2013; 4():19. PubMed ID: 23487556
[TBL] [Abstract][Full Text] [Related]
4. Anthracycline-related cardiotoxicity in childhood cancer survivors.
Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of cancer chemotherapy: implications for children.
Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
[TBL] [Abstract][Full Text] [Related]
6. Cardiac complications of cancer therapies.
Mauro AG; Hunter K; Salloum FN
Adv Cancer Res; 2022; 155():167-214. PubMed ID: 35779874
[TBL] [Abstract][Full Text] [Related]
7. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
Domercant J; Polin N; Jahangir E
Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents.
Briasoulis A; Chasouraki A; Sianis A; Panagiotou N; Kourek C; Ntalianis A; Paraskevaidis I
J Cardiovasc Dev Dis; 2022 Feb; 9(3):. PubMed ID: 35323614
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology: management of cardiovascular toxicity.
Markman TM; Markman M
F1000Res; 2019; 8():. PubMed ID: 30755794
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?
Kenigsberg B; Wellstein A; Barac A
JACC Heart Fail; 2018 Feb; 6(2):87-95. PubMed ID: 29413379
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.
Jain D; Ahmad T; Cairo M; Aronow W
Ann Transl Med; 2017 Sep; 5(17):348. PubMed ID: 28936442
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of Novel Targeted Chemotherapeutic Agents.
Rhea IB; Oliveira GH
Curr Treat Options Cardiovasc Med; 2018 Jun; 20(7):53. PubMed ID: 29922881
[TBL] [Abstract][Full Text] [Related]
15. The concomitant management of cancer therapy and cardiac therapy.
Salvatorelli E; Menna P; Cantalupo E; Chello M; Covino E; Wolf FI; Minotti G
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2727-37. PubMed ID: 25596534
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.
Adão R; de Keulenaer G; Leite-Moreira A; Brás-Silva C
Rev Port Cardiol; 2013 May; 32(5):395-409. PubMed ID: 23623503
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of cancer chemotherapy in clinical practice.
Jain D; Aronow W
Hosp Pract (1995); 2019 Feb; 47(1):6-15. PubMed ID: 30270693
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
Truong J; Yan AT; Cramarossa G; Chan KK
Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
Pai VB; Nahata MC
Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
[TBL] [Abstract][Full Text] [Related]
20. Winning the battle, but losing the war: mechanisms and morphology of cancer-therapy-associated cardiovascular toxicity.
Glass CK; Mitchell RN
Cardiovasc Pathol; 2017; 30():55-63. PubMed ID: 28759820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
